Detiktoday.com – The government has allocated a Covid-19 vaccine budget of Rp 21 trillion in the 2021 state budget. The government has stated that it is ready to produce 100 million Corona virus vaccines if it has passed clinical trials. At present, the vaccine produced by Sinovac Biotech, Ltd. from China is currently undergoing phase three clinical trials.
Member of the House of Representatives Commission IX Intan Fauzi said that his party had held a working meeting with various partners such as the Ministry of Health (Kemenkes) and other institutions, including Bio Farma, related to the third phase clinical trial of Covid-19 vaccine.
“We, as the House of Representatives, of course, in this matter are budget politics, whatever the rupiah, if indeed it means that it is for the people and for the nation and state, such as Perppu and so on, we follow. As long as the budget is properly absorbed and appropriately target, “Intan Fauzi said in a discussion of Democracy Dialectics with the theme” Covid Vaccine: Problem or Solution? ” at the Media Center of the Indonesian Parliament, Senayan, Jakarta, Thursday (07/23/2020).
The PAN faction politician added, for the procurement of the Covid-19 vaccine, the Ministry of Health in the 2021 budget year needed a budget of Rp 21 trillion. Therefore, the most important thing is community access. “The government must be really ready, the people get access to it,” he said.
Intan Fauzi reminded, that clinical trial results must be truly in accordance with World Health Organization (WHO) standards with an efficiency of between 70-80 percent. According to him, the clinical trial process is estimated to still require a very long process. However, the information on the existence of this vaccine caused public euphoria because after all this time undergoing Large-Scale Social Restrictions (PSBB), people were very hopeful that there would be a vaccine that would make this disease manageable.